CamelloPharm SRL
CamelloPharm reported total assets of 122,588 € at the end of the 2025 financial year (annual accounts filed with the NBB on 19 Jun 2026).
The score of CamelloPharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +461 % Total assets -57 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
CamelloPharm's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 24,444 € | ||||
| Equity | 117,797 € | ||||
| Cash | 47,844 € | ||||
| EBITDA | 35,807 € | ||||
| Total assets | 122,588 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 Jun 2026
- Year ended 31 Dec 2024filed on 20 Jun 2025
- Year ended 31 Dec 2023filed on 24 Sep 2024
- Year ended 31 Dec 2022filed on 27 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jul 2022
CamelloPharm's financial analysis
- Solvency96.1%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of CamelloPharm
CamelloPharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0647.992.365
- VAT number
- BE0647992365
- Peppol
- Registered · 0208:0647992365 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Feb 2016
- Registered office
- 8670 Koksijde
- Latest accounts
- 2025 · filed on 19 Jun 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
CamelloPharm (SRL) has been based in Koksijde since 2016, active in: business and other management consultancy activities. For 2025, it reports a net profit of 24,444 € and equity of 117,797 €; its revenue is not published. Its solvency stands at 96.1%, above the median of its sector (58.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to CamelloPharm
Companies in the same business, of comparable size and area, outside its group.
- Fiba Consult Business and other management consultancy activities Beringen · balance sheet 122,606 €
- B4Build Business and other management consultancy activities Ath · balance sheet 122,564 €
- M.M.M.P. Business and other management consultancy activities Waterloo · balance sheet 122,616 €
- TEUN - The Energy Union Business and other management consultancy activities Hasselt · balance sheet 122,616 €
- BC Assist Business and other management consultancy activities Sint-Genesius-Rode · balance sheet 122,636 €
- Stevad Consulting Business and other management consultancy activities Beernem · balance sheet 122,667 €
- Pé VERCA Business and other management consultancy activities Temse · balance sheet 122,490 €
- Definad Business and other management consultancy activities Antwerp · balance sheet 122,481 €
Frequently asked questions about CamelloPharm
What is the revenue of CamelloPharm?
CamelloPharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of CamelloPharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0647992365 for CamelloPharm, if the company is VAT-registered. Its company number (CBE) is 0647.992.365.
Where is the registered office of CamelloPharm?
According to the CBE register, the registered office of CamelloPharm is in 8670 Koksijde.
What is the equity of CamelloPharm?
At the close of the 2025 financial year, the equity of CamelloPharm amounts to 117,797 €, a solvency of 96.1% of total assets.
Who manages CamelloPharm?
The register lists 1 active mandates at CamelloPharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of CamelloPharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →